arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Foghorn Therapeutics Inc.

FHTX

$1.90 ▼ -0.21 (-9.74%) at close

8 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bearish

auto_awesome

Analytical Summary

Foghorn Therapeutics Inc. faces fundamental challenges. On the positive side, Return on Common Equity (%) remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $119.7M

Dividend Yield —

Revenue Growth 36.8% ↗

Op. Margin -279.5% ↗

ROIC 62.9% ↘

FCF / Share $-1.37 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$30.91M

↑ +36.8% —

Net Income Profit after all expenses

$-74.28M

↑ +14.2% —

Operating Margin Operating profit as % of sales

-279.5%

↑ +38.5% 0th

FCF / Share Free cash flow per share

$-1.37

↑ +25.9% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	36.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+359%)	-33.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-523%)	77.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+870%)	1357.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16872%)	206.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2484%)	—	—	—
EPS Growth YoY (%)	25.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	10.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	4.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	14.2% Fair ↑ Fair Improving Year-over-year change in net income	12.0% Fair ↑ Fair Improving Year-over-year change in net income	9.6% Fair ↑ Fair Improving Year-over-year change in net income	-7.5% Weak ↑ Weak Improving Year-over-year change in net income	-47.3% Weak Weak Year-over-year change in net income	-34.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	25.9% Excellent Excellent Year-over-year change in free cash flow	35.1% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—	—	—
Revenue CAGR 3Y (%)	17.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	157.8% Excellent Excellent Compound annual revenue growth over 3 years	329.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	135.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-279.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1963%)	-454.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3129%)	-315.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2206%)	—	—	—	—	—
Effective Tax Rate (%) (%)	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-240.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2103%)	-383.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3294%)	-288.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2501%)	—	—	—	—	—
FCF Margin (%) (%)	-278.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-448.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-349.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-1.77x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	62.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	225.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	146.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-104586.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	52.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-43.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-228.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	68.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+356%)	190.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1168%)	127.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+750%)	—	-104.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-797%)	-47.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	58.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+287%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-78%)	-0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-121%)	—
Interest Coverage (x)	—	—	-30.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-52.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-70.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-94.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-80.88M	$-55.45M	$-80.34M	$-52.21M	$-101.14M	$-73.14M	$-4.02M	—
Debt / EBITDA (x)	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.22x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.49	$0.41	$0.81	$0.46	$0.04	—	—	—
Basic EPS, GAAP (USD)	$-1.18	$-1.58	$-2.34	$-2.62	$-2.73	—	—	—
Free Cash Flow per Share (USD)	$-1.37	$-1.85	$-2.84	$4.63	$-1.44	—	—	—
Book Value per Share (USD)	$-1.92	$-0.82	$-1.83	$0.00	$2.35	$3.97	$-18.07	—
Tangible Book Value per Share (USD)	$-1.92	$-0.82	$-1.83	$0.00	$2.35	$3.97	$-18.07	—
Basic Weighted Avg Shares (shares)	62.98M	54.90M	41.97M	41.59M	37.17M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$103.50M	$182.61M	$181.75M	$296.19M	$410.87M	$171.84M	$4.23M	—
LT Debt (USD)	—	—	—	—	$0.00	$19.65M	$10.96M	—
Total Equity (USD)	$-108.50M	$-45.53M	$-77.19M	$112.00K	$96.87M	$146.19M	$-88.02M	$-39.27M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$30.91M	$22.60M	$34.16M	$19.23M	$1.32M	$430.00K	—	—
Depreciation Expense (USD)	$3.33M	$3.12M	$3.45M	$3.32M	$3.23M	$1.33M	$693.00K	—
Net Income, GAAP (USD)	$-74.28M	$-86.62M	$-98.43M	$-108.88M	$-101.32M	$-68.80M	$-51.13M	—
Operating Cash Flow (USD)	$-86.10M	$-100.41M	$-118.11M	$193.61M	$-50.25M	$-31.29M	$-46.34M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 30 quarters

Foghorn Therapeutics Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FHTX with peers